Difference in risk factors between acute coronary syndrome and stable angina pectoris in the Japanese: Smoking as a crucial risk factor of acute coronary syndrome

Journal of Cardiology

Volumn 55, Issue 3, 2010, Pages 345-353

  Yagi, Hidenori ^a   Komukai, Kimiaki ^a   Hashimoto, Koichi ^a   Kawai, Makoto ^a   Ogawa, Takayuki ^a   Anzawa, Ryuko ^a   Minai, Kosuke ^a   Nagoshi, Tomohisa ^a   Ogawa, Kazuo ^a   Taniguchi, Ikuo ^a   Yoshimura, Michihiro ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute coronary syndrome; Ca channel blocker; Chronic kidney disease; Cigarette smoking; Metabolic syndrome

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; GLITAZONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; SULFONYLUREA;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DYSLIPIDEMIA; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; RISK ASSESSMENT; SMOKING; STABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; ASIAN CONTINENTAL ANCESTRY GROUP; CALCIUM CHANNEL BLOCKERS; CHRONIC DISEASE; FEMALE; HUMANS; KIDNEY DISEASES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SMOKING; SMOKING CESSATION;

EID: 77952237835     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.12.010     Document Type: Article

References (42)

1. Friedman G.D., Petitti D.B., Bawol R.D., and Siegelaub A.B. Mortality in cigarette smokers and quitters. Effect of base-line differences. N Engl J Med 304 (1981) 1407-1410
2. Willett W.C., Green A., Stampfer M.J., Speizer F.E., Colditz G.A., Rosner B., Monson R.R., Stason W., and Hennekens C.H. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 317 (1987) 1303-1309
3. Teo K.K., Ounpuu S., Hawken S., Pandey M.R., Valentin V., Hunt D., Diaz R., Rashed W., Freeman R., Jiang L., Zhang X., Yusuf S., and INTERHEART Study Investigators. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 368 (2006) 647-658
4. Rosenberg L., Kaufman D.W., Helmrich S.P., and Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 313 (1985) 1511-1514
5. Rosenberg L., Palmer J.R., and Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med 322 (1990) 213-217
6. Rea T.D., Heckbert S.R., Kaplan R.C., Smith N.L., Lemaitre R.N., and Psaty B.M. Smoking status and risk for recurrent coronary events after myocardial infarction. Ann Intern Med 137 (2002) 494-500
7. Critchley J.A., and Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 290 (2003) 86-97
8. Keys A, editor. Coronary heart disease in seven countries. Circulation 1970; 41:I1-I211.
9. Fuster V., Badimon L., Badimon J.J., and Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 326 (1992) 242-250
10. Fuster V., Badimon L., Badimon J.J., and Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 326 (1992) 310-318
11. Stary H.C. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 9 (1989) I19-I32
12. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
13. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., and Salonen J.T. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
14. Gami A.S., Witt B.J., Howard D.E., Erwin P.J., Gami L.A., Somers V.K., and Montori V.M. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49 (2007) 403-414
15. Anavekar N.S., McMurray J.J., Velazquez E.J., Solomon S.D., Kober L., Rouleau J.L., White H.D., Nordlander R., Maggioni A., Dickstein K., Zelenkofske S., Leimberger J.D., Califf R.M., and Pfeffer M.A. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
16. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
17. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
18. Thygesen K., Alpert J.S., White H.D., Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Jaffe A.S., Apple F.S., Galvani M., Katus H.A., Newby L.K., Ravkilde J., Chaitman B., Clemmensen P.M., Dellborg M., Hod H., Porela P., et al. Universal definition of myocardial infarction. Circulation 116 (2007) 2634-2653
19. Okamura T., Tanaka H., Miyamatsu N., Hayakawa T., Kadowaki T., Kita Y., Nakamura Y., Okayama A., Ueshima H., and NIPPON DATA80 Research Group. The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis 190 (2007) 216-223
20. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
21. Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 66 (2002) 987-992
22. Hirsch A.T., Haskal Z.J., Hertzer N.R., Bakal C.W., Creager M.A., Halperin J.L., Hiratzka L.F., Murphy W.R., Olin J.W., Puschett J.B., Rosenfield K.A., Sacks D., Stanley J.C., Taylor Jr. L.M., White C.J., et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113 (2006) e463-e654
23. The International Diabetes Federation. IDF Worldwide Definition of the Metabolic Syndrome. http://www.idf.org/home/index.cfm?unode=1120071E-AACE-41D2-9FA0-BAB6E25B A072.
24. Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., Yamagata K., Tomino Y., Yokoyama H., Hishida A., and Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53 (2009) 982-992
25. McKee P.A., Castelli W.P., McNamara P.M., and Kannel W.B. The natural history of congestive heart failure: the Framingham study. N Engl J Med 285 (1971) 1441-1446
26. Ambrose J.A., and Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43 (2004) 1731-1737
27. Holbrook J.H., Grundy S.M., Hennekens C.H., Kannel W.B., and Strong J.P. Cigarette smoking and cardiovascular diseases. A statement for health professionals by a task force appointed by the steering committee of the American Heart Association. Circulation 70 (1984) 1114A-A1117
28. Gotto Jr. A.M. Interactions of the major risk factors for coronary heart disease. Am J Med 80 (1986) 48-55
29. Yokode M., Kita T., Arai H., Kawai C., Narumiya S., and Fujiwara M. Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract. Proc Natl Acad Sci USA 85 (1988) 2344-2348
30. Harats D., Ben-Naim M., Dabach Y., Hollander G., Stein O., and Stein Y. Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis 79 (1989) 245-252
31. Furberg C.D., Psaty B.M., and Meyer J.V. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 92 (1995) 1326-1331
32. Psaty B.M., Heckbert S.R., Koepsell T.D., Siscovick D.S., Raghunathan T.E., Weiss N.S., Rosendaal F.R., Lemaitre R.N., Smith N.L., Wahl P.W., Wagner E.H., and Furberg C.D. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 274 (1995) 620-625
33. Japanese beta-blockers and calcium antagonists myocardial infarction (JBCMI) investigators. Comparison of the effects of beta blockers and calcium antagonists on cardiovascular events after acute myocardial infarction in Japanese subjects. Am J Cardiol 93 (2004) 969-973
34. Yasue H., Omote S., Takizawa A., and Nagao M. Coronary arterial spasm in ischemic heart disease and its pathogenesis. A review. Circ Res 52 (1983) I147-I152
35. Maseri A., Davies G., Hackett D., and Kaski J.C. Coronary artery spasm and vasoconstriction. The case for a distinction. Circulation 81 (1990) 1983-1991
36. Yasue H., and Kugiyama K. Coronary artery spasm: Japanese view. Coronary artery disease 1 (1990) 668-673
37. Yasue H., Nakagawa H., Itoh T., Harada E., and Mizuno Y. Coronary artery spasm-clinical features, diagnosis, pathogenesis, and treatment. J Cardiol 51 (2008) 2-17
38. Kugiyama K., Yasue H., Okumura K., Ogawa H., Fujimoto K., Nakao K., Yoshimura M., Motoyama T., Inobe Y., and Kawano H. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation (1996) 266-272
39. Takaoka K., Yoshimura M., Ogawa H., Kugiyama K., Nakayama M., Shimasaki Y., Mizuno Y., Sakamoto T., and Yasue H. Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: role of cigarette smoking. Int J Cardiol 72 (2000) 121-126
40. Yoshimura M., Yasue H., Nakayama M., Shimasaki Y., Sumida H., Sugiyama S., Kugiyama K., Ogawa H., Ogawa Y., Saito Y., Miyamoto Y., and Nakao K. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 103 (1998) 65-69
41. Nakayama M., Yasue H., Yoshimura M., Shimasaki Y., Kugiyama K., Ogawa H., Motoyama T., Saito Y., Ogawa Y., Miyamoto Y., and Nakao K. T-786-->C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99 (1999) 2864-2870
42. Nakayama M., Yoshimura M., Sakamoto T., Shimasaki Y., Nakamura S., Ito T., Abe K., Yamamuro M., Miyamoto Y., Saito Y., Nakao K., Yasue H., and Ogawa H. Synergistic interaction of T-786-->C polymorphism in the endothelial nitric oxide synthase gene and smoking for an enhanced risk for coronary spasm. Pharmacogenetics 13 (2003) 683-688